Classical and molecular cytogenetics in analysis of diepoxybutane-induced chromosome aberrations

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 419, Issue 1-3, 1998, Pages 155-161

  Sasiadek, Maria ^a   Schlade, Kamilla ^a   Busza, Halina ^a   Czemarmazowicz, Halina ^a   Stembalska, Agnieszka ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Chromosome aberration; Diepoxybutane; FISH

Indexed keywords

BUTADIENE DIEPOXIDE;

ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME PAINTING; CONTROLLED STUDY; CYTOGENETICS; FISH; GIEMSA STAIN; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; LYMPHOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; STANDARD; TECHNIQUE;

AZURE STAINS; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME PAINTING; COLORING AGENTS; EPOXY COMPOUNDS; EVALUATION STUDIES; GENETIC TECHNIQUES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MUTAGENS;

EID: 0032501122     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00131-4     Document Type: Article

References (32)

1. Hsu T.C., Wu X., Trizna Z. Mutagen sensitivity in humans. A comparison between two nomenclature systems for recording chromatid breaks. Cancer Genet. Cytogenet. 87:1996;127-132.
2. Hagmar L., Brogger A., Hansteen I.L., Heim S., Hogstedt B., Knudsen L., Lambert B., Linnainmaa K., Mitelman F., Nordenson I., Reuterwall C., Salomaa S., Skerfving S., Sorsa M. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res. 54:1994;2919-2922.
3. Tucker J.D., Morgan W.F., Awa A.A., Bauchinger M., Blakey D., Cornforth M.N., Littlefield L.G., Natarajan A.T., Shasserre C. A proposed system for scoring structural aberrations detected by chromosome painting. Cytogenet. Cell. Genet. 68:1995;211-221.
4. Dave B.J., Hsu T.C., Hong W.K., Pathak S. Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. Int. J. Oncology. 5:1994;733-740.
5. Tanaka K., Popp S., Fischer C., Van Kaick G., Kamada N., Cremer T., Cremer C. Chromosome aberration analysis in atomic bomb survivors and thorotrast patients using two- and three-colour chromosome painting of chromosomal subsets. Int. J. Radiat. Biol. 70:1996;95-108.
6. Hande M.P., Boei J.J.W.A., Granath F., Natarajan A.T. Induction and persistence of cytogenetic damage in mouse splenocytes following whole-body X-irradiation analysed by fluorescence in situ hybridization: I. Dicentrics and translocations. Int. J. Radiat. Biol. 69:1996;437-446.
7. Knehr S., Zitzelsberger H., Braselmann H., Nahrstedt U., Bauchinger M. Chromosome analysis by fluorescence in situ hybridization: further indications for a non-DNA-proportional involvement of single chromosomes in radiation-induced structural aberrations. Int. J. Radiat. Biol. 70:1996;385-392.
8. Tucker J.D., Ramsey M.J., Lee D.A., Minkler J.L. Validation of chromosome painting as a biodosimeter in human peripheral lymphocytes following acute exposure to ionizing radiation in vitro. Int. J. Radiat. Biol. 64:1993;27-37.
9. Bauchinger M., Schmid E., Zitzelsberger H., Braselmann H., Nahrstedt U. Radiation-induced chromosome aberrations analysed by two-colour fluorescence in situ hybridization with composite whole chromosome-specific DNA probes and a pancentromic DNA probe. Int. J. Radiat. Biol. 64:1993;179-184.
10. Boei J.J., Vermeulen S., Natarajan A.T. Differential involvement of chromosomes 1 and 4 in the formation of chromosomal aberrations in human lymphocytes after X-irradiation. Int. J. Radiat. Biol. 72:1997;139-145.
11. Natarajan A.T., Balajee A.S., Boei J.J.W.A., Darroudi F., Dominguez I., Hande M.P., Meijers M., Slijepcevic P., Vermeulen S., Xiao Y. Mechanisms of induction of chromosomal aberrations and their detection by fluorescence in situ hybridization. Mutat. Res. 372:1996;247-258.
12. Stephan G., Pressl S. Chromosome aberrations in human lymphocytes analysed by fluorescence in situ hybridization after in vitro irradiation, and in radiation workers, 11 years after an accidental radiation exposure. Int. J. Radiat. Biol. 71:1997;293-299.
13. Sasiadek M. Nonrandom distribution of breakpoints in the karyotypes of workers occupationally exposed to benzene. Environ. Health Perspect. 97:1992;255-257.
14. Sorsa M., Peltonen K., Anderson D., Demopoulos N.A., Neumann H.-G., Osterman-Golkar S. Assessment of environmental and occupational exposures to butadiene as a model for risk estimation of petrochemical emissions. Mutagenesis. 11:1996;9-17.
15. Boogaard P.J., Bond J.A. The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro. Toxicol. Appl. Pharmacol. 141:1996;617-627.
16. Kelsey K.T., Wiencke J.K., Ward J., Bechtold W., Fajen J. Sister-chromatid exchanges, glutathione S-transferase θ deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat. Res. 335:1995;267-273.
17. Bernardini S., Hirvonen A., Pelin K., Norppa H. Induction of sister chromatid exchange by 1,2-epoxy-3-butene in cultured human lymphocytes: influence of GSTTI genotype. Carcinogenesis. 19:1998;377-380.
18. Kelsey K.T., Christiani D.C., Wiencke J.K. Bimodal distribution of sensitivity to SCE induction by diepoxybutane in human lymphocytes: II. Relationship to baseline SCE frequency. Mutat. Res. 248:1991;27-33.
19. Landi S., Ponzanelli I., Barale R. Effect of red cells and plasma blood in determining individual lymphocytes sensitivity to diepoxybutane assessed by in vitro induced sister chromatid exchanges. Mutat. Res. 348:1995;117-123.
20. Vlachodimitropoulos D., Norppa H., Autio K., Catalan J., Hirvonen A., Tasa G., Uuskula M., Demopoulos N.A., Sorsa M. GSTT1-dependent induction of centromere-negative and -positive micronuclei by 1,2:3,4-diepoxybutane in cultured human lymphocytes. Mutagenesis. 12:1997;397-403.
21. Landi S., Ponzanelli I., Cipollini G., Frenzilli G., Luccini A., Milillo C.P., Sbrana I., Barale R. Modulating factors of individual sensitivity to diepoxybutane: chromosome aberrations induced in vitro in human lymphocytes. Mutagenesis. 12:1997;17-22.
22. Wiencke J.K., Christiani D.C., Kelsey K.T. Bimodal distribution of sensitivity to SCE induction by diepoxybutane in lymphocytes: I. Correlation with chromosomal aberrations. Mutat. Res. 248:1991;17-26.
23. United Kingdom Environmental Mutagen Society (UKEMS), Report of the UKEMS sub-committee on guidelines for mutagenicity testing, UKEMS, 1984, pp. 43-56.
24. E.J. Tawn, D. Holdsworth, Mutagen-induced chromosome damage in human lymphocytes, in: D.E. Rooney, B.H. Czepulkowski (Eds.), Human Cytogenetics. A Practical Approach, Vol. II, Malignancy and Acquired Abnormalities, IRL Press, 1992, pp. 189-208.
25. P.A. Benn, M.A. Perle, Chromosome staining and banding techniques, in: D.E. Rooney, B.H. Czepulkowski (Eds.), Human Cytogenetics. A Practical Approach, IRL Press, 1986, pp. 57-84.
26. F. Mitelman (Ed.), ISCN (1995): An International System for Human Cytogenetic Nomenclature, S. Karger, Basel, 1995.
27. Lucas J.N., Poggensee M., Straume T. Translocations between two specific human chromosomes detected by three-color chromosome painting. Cytogenet. Cell Genet. 62:1993;11-12.
28. Tucker J.D., Preston R.J. Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment. Mutat. Res. 365:1996;147-159.
29. Cohen O., Cans C., Cuillel M., Gilardi J.L., Roth H., Mermet M.A., Jalbert P., Demongeot J. Cartographic study: breakpoints in 1574 families carrying human reciprocal translocations. Hum. Genet. 97:1996;659-667.
30. Norppa H. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ. Health Perspect. 105:1997;. Suppl. 4.
31. F. Mitelman, Catalog of Chromosome Aberrations in Cancer, 5th edn., Wiley, New York, 1994.
32. Columna E.A., Giaccia A.J., Evans J.W., Yates B.L., Morgan W.F. Analysis of restriction enzyme-induced chromosomal aberrations by fluorescence in situ hybridization. Environ. Mol. Mutagen. 22:1993;26-33.